This is the authors' abstract. We don't add key points for this paper.
In 6 growth hormone-deficient children, we have demonstrated that 3-N-demethylation of caffeine as measured by the 13CO2 caffeine breath test is decreased following 1 month of growth hormone therapy (8.4 +/- 1.0 vs. 6.8 +/- 1.2% 13C/2 h after treatment). These findings could be of clinical importance. The initiation of growth hormone therapy in growth hormone-deficient children could alter the clearance of drugs metabolized through the mixed-function oxidase pathway given for concurrent conditions, and necessitate adjustment of the therapeutic regimen.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Levitsky et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: